Reproductive decision-making in young female carriers of a BRCA mutation

Human Reproduction

Volumn 28, Issue 4, 2013, Pages 1006-1012

  Donnelly, L S ^a   Watson, M ^b,c   Moynihan, C ^b,d   Bancroft, E ^d   Evans, D G R ^e   Eeles, R ^d   Lavery, S ^f   Ormondroyd, E ^g  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

^g JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

BRCA; cancer; ethics; preimplantation genetic diagnosis; reproductive decisions

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COHORT ANALYSIS; ETHNIC DIFFERENCE; FAMILY PLANNING; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENETIC SERVICE; HUMAN; MOTIVATION; PATIENT ATTITUDE; PATIENT DECISION MAKING; QUALITATIVE ANALYSIS; RISK MANAGEMENT; SEMI STRUCTURED INTERVIEW; SOCIAL ASPECT; THEMATIC ANALYSIS;

EID: 84875633398     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des441     Document Type: Article

References (37)

1. Adam S, Wiggins S, Whyte P, Bloch M, Shokeir MH, Soltan H, Meschino W, Summers A, Suchowersky O, Welch JP et al. Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment. J Med Genet 1993; 30: 549-556.
2. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003; 72: 1117-1130.
3. Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B. Psychological distress among women seeking genetics counselling for breast-ovarian cancer risk: the contribution of personality and appraisal. Ann Behav Med 1997; 19: 370-377.
4. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3: 77-101.
5. Decruyenaere M, Evers-Kiebooms G, Boogaerts A, Philippe K, Demyttenaere K, Dom R, Vandenberghe W, Fryns JP. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation. Eur J Hum Genet 2007; 15: 453-462.
6. Downing C. Negotiating responsibility: case studies of reproductive decision-making and prenatal genetic testing in families facing Huntington disease. J Genet Couns 2005; 14: 219-234.
7. Evans DG, Howell A. Are BRCA1- and BRCA2- related breast cancers associated with increased mortality? Breast Cancer Res 2004; 6: e7.
8. Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 2008; 8: 155.
9. Fortuny D, Balmañ a J, Grañ a B, Torres A, Ramó n y Cajal T, Darder E, Gadea N, Velasco A, Ló pez C, Sanz J et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod 2009; 24: 1000-1006.
10. Foster C, Evans DGR, Eeles R, Eccles D, Ashley S, Brooks L, Davidson R, Mackay J, Morrison PJ, Watson M. Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002; 86: 1209-1216.
11. Geraedts JP, DeWert GM. Preimplantation Genetic Diagnosis. Clin Genet 2009; 76: 315-325.
12. Gigerenzer G, Gaissmaier W. Heuristic decision-making. Ann Rev Psychol 2011; 62: 451-482.
13. Hallowell N. Doing the right thing: genetic risk and responsibility. Sociol Health Ill 1999; 21: 597-621.
14. Hastie R, Bawes RM. Rational Choice in an Uncertain World: The Psychology of Judgment and Decision-Making. CA: Sage publications, 2010.
15. Hershberger PE, Pierce PF. Conceptualizing couples' decision-making in PGD: Emerging cognitive, emotional and moral dimensions. Patient Educ Couns 2010; 81: 53-62.
16. Human Fertilisation and Embyology Act. London: HMSO, 1990.
17. HFEA. 2006. Choices and Boundaries - public discussion summary. Available at: http://www.hfea.gov.uk/docs.Choices-and-boundaries-Report-2006-summary.pdf. (6 August 2010, date last accessed).
18. Kastrinos F, Stoffel E, Balmana J, Syngal S. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol 2007; 102: 1284-1290.
19. Lancaster JM, Wiseman RW, Berchuck A. An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene. Obstet Gynecol 1996; 87: 306-309.
20. Marteau TM, Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing? Am J Med Genet 2001; 106: 185-190.
21. Menon U, Harper J, Sharma A, Fraser L, Burnell M, ElMasry K, Rodeck C, Jacobs I. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007; 22: 1573-1577.
22. Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst 2002; 94: 1564-1569.
23. Novas C, Rose N. Genetic risk and the birth of the somatic individual. Econ Soc 2000; 29: 485-513.
24. Offredy M, Kendall S, Goodman C. The use of cognitive continuum theory and patient scenarios to explore nurse prescribers' pharmacological knowledge and decision-making. Int J Nurs Stud 2008; 45: 855-868.
25. Ormondroyd E, Donnelly LS, Moynihan C, Savona C, Bancroft C, Evans DG, Eeles R, Lavery SA, Watson M. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. Eur J Hum Genet 2012; 20: 4-10.
26. Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2009; 91: 2361-2368.
27. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reducing estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 2009; 101: 80-87.
28. Rowley E. On doing 'being ordinary': women's accounts of BRCA testing and maternal responsibility. New Genet Soc 2007; 26: 241-250.
29. Sandelowski M, Barroso J. The travesty of choosing after positive prenatal diagnosis. J Obstet Gynecol Neonatal Nurs 2005; 34: 307-318.
30. Schover LR. A lesser evil: prophylactic mastectomy for women at high risk for breast cancer. J Clin Oncol 2008; 26: 3918-3919.
31. Smith KR, Ellington L, Chan AY, Croyle RT, Botkin Jr. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 2004; 13: 733-740.
32. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008; 7: 179-186.
33. Taylor SD. Predictive genetic testing for Huntington's disease: context, appraisal and moral imperatives. Soc Sci Med 2004; 58: 137-149.
34. Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Science 1974; 185: 1124-1131.
35. vanDooren S, Rijnsburger AJ, Seynaeve C, Duivenvoorden HJ, Essink-Bot ML, Tilanus-Linthorst MM, de Koning HJ, Tibben A. Psychological distress in women at increased risk of breast cancer: the role of risk perception. Eur J Cancer 2004; 40: 2056-2063.
36. Watson M. Foster C, Eeles R, Eccles D, Ashley S, Davidson R, Mackay P, Morrison J, Hopwood P, Evans DGR, Psychosocial study collaborators. Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 2004; 91: 1787-1794.
37. Zeleny M. Multiple Criteria Decision-Making. New York: McGraw-Hill, 1982.